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Abstract
Lichen planus is a fairly common chronic idiopathic dis-
order of the skin, nails and mucosal surfaces. Esopha-
geal involvement of this disease on the other hand is 
rare and only about 50 cases have been reported in 
literature. Given its rarity, it can be difficult to diagnose 
and may be easily misdiagnosed as reflux esophagitis. 
Currently, there are no clear recommendations on the 
optimal management of this disease and little is known 
about the best treatment approach. Systemic steroids 
are usually the first line treatment and offer a favor-
able response. In this report, we would like to present 
a novel approach in the management of esophageal 
lichen planus in a middle-aged woman treated suc-
cessfully with swallowed fluticasone propionate 220 
mcg twice a day for 6 wk, as evidenced by objective 
clinical findings. Based on our review of related litera-
ture and experience in this patient, we feel that a trial 
of swallowed fluticasone may be a prudent approach in 
the management of these patients since it has a more 
favorable side effect profile than systemic treatment.
© 2013 Baishideng. All rights reserved.
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INTRODUCTION
Lichen planus is a well-recognized chronic idiopathic 
disorder involving the skin, nails and mucosal surfaces 
including the mouth, pharynx and perineum[1]. It af-
fects less than 1% of  the general population[2]. Mucosal 
surface involvement is found in about 30%-70% of  
patients diagnosed with lichen planus[3]. Esophageal in-
volvement, on the other hand, is considered to be rare 
with its true prevalence unknown. The study by Dickens 
et al[4] demonstrated esophageal lichen planus in 26% 
of  patients with mucocutaneous lesions while a larger 
study by Eisen[5] found esophageal lesions in only 1% of  
patients. Here we describe a case of  esophageal lichen 
planus who was treated with swallowed fluticasone with 
good response and present a review of  this topic.
CASE REPORT
A 63-year-old female with history of  gastric bypass sur-
gery, coronary artery disease, and hyperlipidemia report-
ed having intermittent solid food dysphagia for the past 3 
years. She also had symptoms of  gastroesophageal reflux 
disease that was initially controlled with omeprazole 20 
mg daily. Later on, she developed multiple episodes of  
breakthrough and nocturnal reflux symptoms accompa-
nied by occasional difficulty in swallowing large pills that 
happened 2-3 times a week. She denied food regurgita-
tion, odynophagia, nausea, vomiting or weight loss. For 
further evaluation of  her dysphagia, a barium swallow 
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was performed. During the procedure, the barium pill 
briefly got trapped in the upper esophagus at the level 
of  C6-C7. This location correlated with the reported site 
of  dysphagia (Figure 1). The rest of  the exam was un-
eventful and no mass or stricture was noted except for a 
small sliding hiatal hernia. She subsequently underwent 
an upper endoscopy which showed areas of  friable mu-
cosa and dried blood in the upper esophagus with a mild 
to moderate stricture at the upper and mid-esophageal 
junction (Figure 2). Esophageal biopsies were obtained 
which showed hyperkeratosis, parakeratosis and spongi-
osis of  the lower third of  the epithelium with focal dys-
keratosis. Chronic inflammatory cell infiltration of  the 
epithelium was also present and was mainly composed 
of  lymphocytes (Figure 3). Submucosa was not present 
for evaluation of  lichenoid inflammation. Nonetheless, 
in the presence of  the clinical history, the findings were 
interpreted to be consistent with lichen planus. On fur-
ther questioning, patient reported having an oral lesion 
diagnosed to be lichen planus in 2009. Due to her his-
tory of  previous lichen planus and endoscopy findings, 
patient was diagnosed with esophageal lichen planus and 
was started on swallowed fluticasone propionate 220 
mcg twice daily for 6 wk. At her 4th wk follow-up she 
noted resolution of  her symptoms. On follow-up endos-
copy at 15 wk, only small light pink plaques were noted 
in the mid-esophagus while the rest of  the esophagus 
showed normal looking mucosa (Figure 4). Pathology 
Figure 1  Barium swallow showing barium pill (arrow) trapped in C6-C7.
Figure 2  Endoscopy image showing friable mucosa and dried blood in 





Figure 3  Chronic inflammatory cell infiltration of the epithelium was also 
present and was mainly composed of lymphocytes. A: Low power view of 
upper esophagus shows extensive severe keratinization, organizational disar-
ray of cell arrangement and spongiosis of lower layer associated with inflamma-
tory infiltration. (E, × 40); B: High power of parakeratotic cells and accumulation 
of keratohyaline granules in the cytoplasm of the mature keratinocytes. In this 
zone keratinization is mild. (HE, × 400); C: High power view of spongiosis of 
lower layers of squamous epithelium associated with sprinkling of lymphocytes 
typical of longstanding chronic inflammation. (HE, × 400).
Figure 4  Endoscopy image showing resolution of lesions in the upper 
esophagus post treatment. 
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showed normal to atrophic squamous mucosa with mild 
non-specific inflammation including rare eosinophils and 
no evidence of  interface band-like lymphocytic infiltrate 
which was compatible with lichen planus post-therapy. 
DISCUSSION
Lichen planus is a common disorder of  squamous epi-
thelium[2]. The exact cause of  this disease is unknown; 
however infectious (viral), neurologic, genetic and im-
munologic causes have been proposed[6]. Lichen planus 
appears to be mediated by cytotoxic CD8+ T cells that 
attack an antigen in the basal epithelium in a manner re-
sembling graft-versus-host disease[2]. There are no detailed 
studies published to specifically address the pathogenesis 
of  esophageal lichen planus. Chandan et al[7] suggests that 
the pathogenesis may be similar to oral lichen planus. 
It has been suggested that oral lichen planus is due to 
an immune response to an exogenous or endogenous 
antigen found in the basal keratinocytes. This activates 
the Langerhans cells which then present the antigen to 
the CD4+ T lymphocytes migrating to the oral mucosa 
lamina propria. Keratinocytes respond to the injury by 
producing cytokines that promote CD8+ T lymphocyte 
stimulation. These CD8+ cytotoxic cells will distribute 
near the epithelium and destroy it[8]. Table 1 summarizes 
the differences between esophageal vs oral and cutaneous 
lichen planus. 
Esophageal lichen planus is considered to be a rare 
disease with only about 50 cases reported in English lit-
erature. Retrospectively, Eisen[5] suggests a prevalence of  
less than 1% among patients with oral lichen planus but 
because of  subtle clinical findings and lack of  character-
istic histologic features, the true prevalence is hard to de-
termine[9]. All reported patients are usually middle-aged 
females except in the study by Chryssostalis et al[10] that 
reported a case of  a 22-year-old male with esophageal 
involvement. Esophageal lichen planus is often present 
in patients with extraesophageal involvement, but it may 
also be present in patients without dermal or oropha-
ryngeal manifestations[11]. In a case series of  esopha-
geal lichen planus, the initial site of  involvement was 
esophagus in 48% of  patients[12]. Symptoms can range 
from asymptomatic to odynophagia and dysphagia[4]. 
The proximal or mid-esophagus is the most common 
site of  involvement[7], although the entire esophagus can 
also be affected with sparing of  the gastroesophageal 
junction[13]. Different types of  lesions have been repor-
ted and can range from elevated lacy white papules, 
esophageal webs, pseudomembranes, desquamation, and 
superficial pinpoint erosions with and without stenosis. 
Most case reports mention the characteristic finding of  
peeling of  the mucosa away from the esophagus leav-
ing a friable, inflamed surface that bleeds on contact[11]. 
Strictures are also common in these patients and may 
represent progression from inflammation to ulceration, 
fibrosis with subsequent stricture formation[14].
Esophageal lichen planus may be misdiagnosed as re-
flux esophagitis which further compounds the situation. 
In our patient, esophageal lichen planus was favored over 
reflux esophagitis due to the extensive degree of  hyper-
keratosis and focal parakeratosis with accumulation of  
keratohyaline granules which are unlikely in reflux related 
injury. The presence of  spongiosis in the lower third of  
the epithelium was also more consistent with esophageal 
lichen planus. The spongiosis in reflux diseases tend to 
occur in the upper third of  the epithelium where acid 
is in contact with the mucosa. The other factor that can 
help to differentiate these 2 entities is the site of  involve-
ment in the esophagus. While reflux disease is usually 
more severe in the distal esophagus, lichen planus affects 
the middle and upper esophagus in most cases.





No gender preference No gender preference Generally middle aged females1
Clinical 
findings
Eruptions of violaceous, scaling, pruritic 
plaques[7]
Atrophic lesions, erosions, lace-like 
reticulated plaques[2]
Elevated lacy white papules, esophageal 
webs, pseudomembranes, desquamation, 




Self-limited with spontaneous regression in 
1-2 yr[21]




acanthosis and “saw-tooth” elongation of the 
rete pegs[21]
Oral lesions closely resemble esophageal 
lesions
Parakeratosis, atrophic epithelium, lacks 
hypergranulosis, variable thinning or 
acanthosis[21]
Typical band-like inflammatory infiltrate 
with a predominance of mature T cells 
and basal layer degeneration including 
characteristic Civatte bodies (i.e., apoptotic 
basal keratinocytes)[21]
Typical band-like inflammatory infiltrate 
with a predominance of mature T cells 
and basal layer degeneration including 
characteristic Civatte bodies (i.e., apoptotic 
basal keratinocytes)[21]
Typical band-like inflammatory infiltrate 
with a predominance of mature T cells 
and basal layer degeneration including 




No increased risk of malignant 
transformation 
Increased risk of oral malignancy; 
Associated with hepatitis C
Some case reports have shown malignancy 
associated with esophageal lichen planus
1One report by Chryssostalis et al[10] showed esophageal lichen planus in a 22-yr-old male patient.
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The most characteristic histologic finding in esopha-
geal lichen planus is a bandlike or lichenoid lymphocytic 
infiltrate involving the superficial lamina propria and 
basal epithelium[7]. A predominance of  mature T cells is 
present within this infiltrate. These are associated with 
basal keratinocyte degeneration which often include Civa-
tte bodies (necrotic keratinocytes with anucleate rem-
nants)[7]. Lymphocytic infiltration of  the mucosa is not 
pathognomonic of  this disease and medications such 
as gold, thiazide, and anti-malarials can induce lichen 
planus-like lesions and need to be excluded clinically[15]. 
No clear guidelines are present for the treatment of  
esophageal lichen planus and there is no specific way 
to treat this entity. Historically, systemic corticosteroids 
have been used as first-line treatment with a response 
rate of  up to 74% based on multiple reports. However, 
relapse rate can be as high as 85% with steroid with-
drawal[11]. Treatment response was also reported with 
adrenocorticotrophic hormone injection, etretinate, topi-
cal tacrolimus, intralesional corticosteroids and cyclospo-
rine[2,16]. Esophageal dilation is commonly used to treat 
strictures, although intralesional steroid injections and/or 
oral tacrolimus may decrease the frequency of  required 
dilations. It is important to note that koebner phenom-
enon which is defined as development of  new lesions 
along the lines of  trauma, can occur with dilatation.
Although effective, systemic corticosteroid treatment 
can be associated with serious side effects and therefore 
there is a need for a safer alternative. In our review of  
literature, we have come upon case reports and a recent 
case series where treatment with swallowed fluticasone 
proprionate has resulted in symptomatic improvement 
as well as endoscopic improvement in 4 out 6 treated pa-
tients[14,17]. Because of  these promising results, we decided 
to try this novel approach for our patient which proved 
to be successful. 
Oral lichen planus has a 1%-3% risk of  malignant 
transformation to squamous cell carcinoma[3]. It is un-
known however if  the same is true for esophageal lichen 
planus. To date, 3 case reports have described squamous 
cell carcinoma and 1 described a verrucous carcinoma 
arising from these lesions[10,18,19]. In these reports, squa-
mous cell carcinoma developed more than 20 years after 
the diagnosis of  esophageal lichen planus[18]. Due to this 
risk, some advocated surveillance endoscopies in patients 
with esophageal lichen planus to detect early malignancy. 
In the study by Quispel et al[20], high magnification indigo 
carmine chromoendoscopy was used to establish the 
prevalence of  endoscopic and histopathologic esophageal 
abnormalities consistent with lichen planus and dysplasia 
in a cohort of  patients with lichen planus. It was found 
that up to 50% of  patients with orocutaneous lichen 
planus had esophageal involvement but no dysplasia was 
found. The authors of  this study proposed to set a low 
threshold for performing endoscopy in patients with 
lichen planus and symptoms suggestive of  esophageal in-
volvement but recommended against routine screening[20]. 
Based on these data, we recommend that the frequency 
of  screening by endoscopy be individualized, but the 
possibility of  malignancy be kept in mind while evaluat-
ing these patients with a low threshold for further evalua-
tion in patients with symptoms suggestive for esophageal 
cancer.
In conclusion, esophageal lichen planus should be 
suspected in middle-aged female patients who present 
with symptoms of  dysphagia and odynophagia and found 
to have mucosal abnormalities involving the upper third 
of  the esophagus. Once the diagnosis of  esophageal li-
chen planus is made, these patients should be considered 
for treatment with swallowed fluticasone before other 
systemic and more toxic therapies. It is important to keep 
in mind that secondary to the risk for malignant transfor-
mation, these patients should be followed closely. 
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